Skip to main content
Home

Oncologieportal

Main navigation

  • Oncologieportal
    • Borst
    • Endocrinologie
    • Gastro-Enterologie
    • Gynaecologie
    • Hematologie
    • Hoofd-Halsgebied
    • Huid
    • Long/Mesotheliomen
    • Neurologie
    • Pediatrie
    • Sarcoom
    • Urologie en Nefrologie
  • Medi-Access
background_placeholder
diffuse large b-cell lymphoma

Articles about diffuse large b-cell lymphoma

     
Kies meer
In Trending

Diffuse large B?cell lymphoma of the Waldeyer’s ring: A U.S. Populatio...

In Trending

Dual Epigenetic Agents plus Rituximab?Gemcitabine?Oxaliplatin as Salva...

International Journal of Laboratory Hematology
In Wetenschap

Haematology laboratory parameters to assess efficacy of CD19-, CD22-, ...

In Trending

NR1H3 (LXR?) IS ASSOCIATED WITH PRO?INFLAMMATORY MACROPHAGES, PREDICTS...

Biology of Blood and Marrow Transplantation
In Trending

Socioeconomic and Racial Disparity in Chimeric antigen receptor T cell...

In Trending

Risk factors for cardiovascular events and mortality in patients diagn...

PMLiVE
In Trending

Roche’s Polivy receives EC approval for lymphoma therapy

Leukemia
In Wetenschap

MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA...

Trending

Er zijn @count nieuwe artikelen
Tuesday, August 9, 2022 - 17:16 - In Trending
Diffuse large B?cell lymphoma of the Waldeyer’s ring: A U.S. Population?based survival analysis
Wednesday, July 20, 2022 - 15:24 - In Trending
Dual Epigenetic Agents plus Rituximab?Gemcitabine?Oxaliplatin as Salvage Treatment in Relapsed/Refractory Diffuse Large B?Cell Lymphoma Patients Failure of Salvage Chemotherapy
Tuesday, July 19, 2022 - 13:32 - In Wetenschap
Haematology laboratory parameters to assess efficacy of CD19-, CD22-, CD33-, and CD123-directed chimeric antigen receptor T-cell therapy in haematological malignancies
Tuesday, July 19, 2022 - 11:32 - In Trending
NR1H3 (LXR?) IS ASSOCIATED WITH PRO?INFLAMMATORY MACROPHAGES, PREDICTS SURVIVAL AND SUGGESTS POTENTIAL THERAPEUTIC RATIONALES IN DIFFUSE LARGE B?CELL LYMPHOMA
Thursday, June 30, 2022 - 04:40 - In Trending
Socioeconomic and Racial Disparity in Chimeric antigen receptor T cell (CART)Therapy Access
Sunday, May 29, 2022 - 11:24 - In Trending
Risk factors for cardiovascular events and mortality in patients diagnosed with DLBCL and treated with Anthracyclines
Thursday, May 26, 2022 - 14:32 - In Trending
Roche’s Polivy receives EC approval for lymphoma therapy
Friday, April 29, 2022 - 12:16 - In Wetenschap
MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ›› Next page
  • » Last page

Kies uw tags

Liposarcoma
teratoma
endometrial cancer
AML
ovarian carcinoma
Craniopharyngioma
cholangiocarcinoma
gastric cancer
uterine leiomyoma
intestinal cancer

Medzine logo gekleurd

Word op de hoogte gehouden van de laatste ontwikkelingen binnen oncologie via MedZine. Het nieuws wordt samengesteld uit meer dan 4.700 wetenschappelijke journals, beroepsverenigingen en andere gezaghebbende websites.

Sitemap

  • Trending
  • Wetenschappelijk
  • Uw nieuws

Support

  • Contact
  • Privacyverklaring
  • Gebruik van cookies

Medix

FTO

CEFI

 CME Academy

FarmacoTherapie Online

Medi-Access